Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis-Reference-Cited by-同舟云学术

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

Published:2024-04 Issue:4 Volume:14 Page:983-992
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Torres Tiago^ORCID,Sohrt Petersen Anne^ORCID,Ivens Ulla^ORCID,Bosch Vilaro Albert^ORCID,Stinson John^ORCID,Carrascosa José Manuel^ORCID

Funder

LEO Pharma

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s13555-024-01143-x.pdf

Reference26 articles.

1. Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23:S115–23.

2. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387:1109–22.

3. Capucci S, Hahn-Pedersen J, Vilsbøll A, Kragh N. Impact of atopic dermatitis and chronic hand eczema on quality of life compared with other chronic diseases. Dermatitis. 2020;31:178–84.

4. Silverberg JI, Garg NK, Paller AS, Fishbein AB, Zee PC. Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Invest Dermatol. 2015;135:56–66.

5. Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121:340–7.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-13 Inhibitors in the Treatment of Atopic Dermatitis: The Role of Tralokinumab;Dermatology Practical & Conceptual;2024-07-31